Clarissa

Red Light Therapy for Sleep: Two Claims Worth Separating

Red light therapy for sleep marketing typically bundles two genuinely different claims together, and separating them matters. The first claim, that red light doesn’t suppress melatonin the way blue light does, is well-established photobiology: the eye’s melanopsin-containing cells that regulate your circadian clock are far more sensitive to blue wavelengths than red ones. The second,

Red Light Therapy for Sleep: Two Claims Worth Separating Read More »

Binaural Beats for Sleep: What the Research Actually Covers

Binaural beats for sleep are often promoted with a specific, impressive-sounding statistic, a 2019 meta-analysis finding a “medium, significant” effect size across 22 studies, but it’s worth knowing that meta-analysis measured effects on cognition, anxiety, and pain, not sleep specifically. The phenomenon itself is real: when you hear two slightly different tones in each ear,

Binaural Beats for Sleep: What the Research Actually Covers Read More »

THC and Sleep: The REM Question Isn’t Settled

THC and sleep have a more genuinely contested relationship than “cannabis suppresses REM sleep” suggests, and that’s worth understanding before treating either claim as settled. Classic cannabis research consistently found THC heavily suppresses REM sleep. But a 2025 systematic review found that modern studies using lower, therapeutic doses often don’t replicate this effect, and one

THC and Sleep: The REM Question Isn’t Settled Read More »

Ozempic and Sleep Apnea: What the Real Trial Data Shows

“Ozempic and sleep apnea” is a common search, but the strongest, FDA-approved evidence here actually belongs to a different, related drug. Tirzepatide (sold as Zepbound for weight management and Mounjaro for diabetes) became the first and only FDA-approved medication specifically for moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity, based on results from the

Ozempic and Sleep Apnea: What the Real Trial Data Shows Read More »